Our results showed marked upregulation of phosphate-ERK1/2 (p-ERK1/2) in PRSS22-overexpressing BC cells, whereas PRSS22 knockdown significantly decreased the expression of p-ERK1/2 (Fig. 5C–F). Here, MAPK3 is linked to breast cancer.